CAS: 1029044-16-3 - Plx 3397
Fórmula:C20H15ClF3N5
InChI:InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)
Clave InChI:InChIKey=JGWRKYUXBBNENE-UHFFFAOYSA-N
SMILES:FC(F)(F)C1=NC=C(C=C1)CNC2=NC=C(C=C2)CC3=CNC=4N=CC(Cl)=CC43
Ref: 7W-GP8518
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
Ref: 4Z-K-031070
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Pexidartinib
CAS:1029044-16-3
Pexidartinib (PLX-3397) is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of …
Fórmula:
C20H15ClF3N5
Pureza:
99.66%
Forma y color:
Solid
Peso molecular:
417.81
Ref: TM-T2115
| 1g | 572,00 € | |
| 2g | 838,00 € | |
| 5mg | 53,00 € | |
| 10mg | 67,00 € | |
| 25mg | 99,00 € | |
| 50mg | 124,00 € | |
| 100mg | 156,00 € | |
| 200mg | 204,00 € | |
| 500mg | 345,00 € | |
| 1ml*10 (DMSO) | 54,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Pexidartinib
CAS:1029044-16-3
Inhibitor of CSF1R receptor
Fórmula:
C20H15ClF3N5
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
417.81 g/mol
Ref: 3D-FP76492
| 25mg | 110,00 € | |
| 50mg | 155,00 € | |
| 100mg | 211,00 € | |
| 250mg | 426,00 € | |
| 500mg | 582,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
![N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine](https://static.cymitquimica.com/products/AN/thumb/AG0039N8.jpg)
N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine
CAS:1029044-16-3
Fórmula:
C20H15ClF3N5
Pureza:
98%
Forma y color:
Solid
Peso molecular:
417.8148
Ref: AN-AG0039N8
| 1mg | Descatalogado | |
| 5mg | Descatalogado | |
| 10mg | Descatalogado | |
| 50mg | Descatalogado | |
| 100mg | Descatalogado |
